Post COVID-19 Vaccine Related Cerebral Venous Sinus Thrombosis and Thrombocytopenia

During the height of the COVID-19 pandemic, there was great relief with the global mass rollout of the Covid-19 vaccination programs. While they have proven to be safe and effective, the gradual emergence of side effects to the vaccines has undermined public trust in the vaccination program and, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler- Manuel, William, Rana, Usman Iqbal, Zafar, Mansoor, Gadi, Azeem, Kiani, Amarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733850/
https://www.ncbi.nlm.nih.gov/pubmed/35004085
http://dx.doi.org/10.7759/cureus.20932
Descripción
Sumario:During the height of the COVID-19 pandemic, there was great relief with the global mass rollout of the Covid-19 vaccination programs. While they have proven to be safe and effective, the gradual emergence of side effects to the vaccines has undermined public trust in the vaccination program and, whilst rare, can lead to significant morbidity and mortality. The most serious was the emergence of vaccine-induced immune thrombocytopenia and thrombosis (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS) or vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). VITT is a serious and often fatal complication of some COVID vaccines that seem more prevalent in younger people and women. We present a case of a 48-year-old woman who presented with VITT following COVID vaccination.

Ejemplares similares